A new PCR-SSP typing method for six single-nucleotide polymorphisms impairing the blood-clotting cascade as well as T-cell stimulation

Tissue Antigens

Volumn 66, Issue 6, 2005, Pages 650-655

  Meyer, M ^a   Czachurski, D ^a   Hien, T ^a   Opelz, G ^a   Mytilineos, Joannis ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

CD28; CTLA4; Factor V Leiden; MTHFR; PCR SSP; Prothrombin; SNP

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5; CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; PROTHROMBIN;

3' UNTRANSLATED REGION; AMINO ACID SEQUENCE; ARTICLE; AUTOIMMUNE DISEASE; BLOOD CLOTTING; CAUCASIAN; CONTROLLED STUDY; EXON; FEMALE; GENE AMPLIFICATION; GENOTYPE; GERMANY; HUMAN; HUMAN CELL; HYPERCOAGULABILITY; INTRON; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MALE; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SCREENING; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; THROMBOSIS;

ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, DIFFERENTIATION; BLOOD COAGULATION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FACTOR V; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GERMANY; HUMANS; LYMPHOCYTE ACTIVATION; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTHROMBIN; T-LYMPHOCYTES;

EID: 27944443688     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2005.00493.x     Document Type: Article

References (34)

1. Tomer Y, Greenberg DA, Barbesino G, Concepcion E, Davies TF. CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production. J Clin Endocrinol Metab 2001: 86: 1687-93.
2. Deichmann K, Heinzmann A, Bruggenolte E, Forster J, Kuehr J. An Mse I RFLP in the human CTLA4 promotor. Biochem Biophys Res Commun 1996: 225: 817-8.
3. Ahmed S, Ihara K, Kanemitsu S et al. Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus erythematosus in the Japanese population. Rheumatology 2001: 40: 662-7.
4. Bertina RM, Koeleman BP, Koster T. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994: 369: 64-7.
5. Wuthrich RP, Cicvara-Muzar S, Booy C, Maly FE. Heterozygosity for the factor V Leiden (G1691A) mutation predisposes renal transplant recipients to thrombotic complications and graft loss. Transplantation 2001: 72: 549-50.
6. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996: 88: 3698-703.
7. Forssmann U, Mytilineos J, Scherer S, Opelz G. A method for HLA-DQA typing by the PCR-SSP technique. Transplant Int 1994: 7: 515-8.
8. http://cts.med.uni-heidelberg.de/public/reagents.html.
9. Sheppard CW. Computer simulation of stochastic processes through model-sampling (Monte Carlo) techniques. FEBS Lett 1969: 2 (Suppl. 1): 14-21.
10. Livak KJ. Allelic discrimination using fluorogenic probes and the 5′nuclease assay. Genet Anal 1999: 14: 143-9.
11. Blondal T, Waage BG, Smarason SV et al. A novel MALDITOF based methodology for genotyping single nucleotide polymorphisms. Nucleic Acids Res 2003: 31: 155.
12. Doi K, Doi H, Noiri E, Nakao A, Fujita T, Tokunaga K. High-throughput single nucleotide polymorphism typing by fluorescent single-strand conformation polymorphism analysis with capillary electrophoresis. Electrophoresis 2004: 25: 833-8.
13. Hessner MJ, Luhm RA, Pearson SL, Endean DJ, Friedmann KD, Montgomery RR. Prevalence of prothrombin G20210A, factor V G1691A (Leiden), and methylenetetrahydrofolate reductase (MTHFR) C677T in seven different populations determined by multiplex allele-specific PCR. Thromb Haemost 1999: 81: 733-8.
14. Hessner MJ, Budish MA, Friedmann KD. Genotyping of factor V G1691A (Leiden) without the use of PCR by invasive cleavage of oligonucleotide probes. Clin Chem 2000: 46: 1051-6.
15. Bowen DJ, Bowley S, John M, Collins PW. Factor V Leiden (G1691A), the prothrombin 3′-untranslated region variant (G20210A) and thermolabile methylenetetrahydrofolate reductase (C677T): a single genetic test genotypes all three loci - determination of frequencies in the S. Wales population of the UK. Thromb Haemost 1998: 79: 949-54.
16. Hessner MJ, Dinauer DM, Kwiatkowski R, Neri B, Raife TJ. Age-dependent prevalence of vascular disease-associated polymorphisms among 2689 volunteer blood donors. Clin Chem 2001: 47: 1879-84.
17. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995: 346: 1133-4.
18. Bauer KA, Humphries S, Smillie B. Prothrombin activation is increased among asymptomatic carriers of the prothrombin G20210A and factor V Arg506Gln mutations. Thromb Haemost 2000: 84: 396-400.
19. Fodinger M, Wolfl G, Fischer G. Effect of MTHFR 677C/T on plasma total homocysteine levels in renal graft recipients. Kidney Int 1999: 55: 1072-80.
20. Marder BA, Schröppel B, Lin M et al. The impact of costimulatory molecule gene polymorphisms on clinical outcomes in liver transplantation. Am J Transplant 2003: 3: 424-31.
21. Middendorf K, Gohring P, Huehns TY, Seidel D, Steinbeck G, Nikol S. Prevalence of resistance against activated protein C resulting from factor V Leiden is significantly increased in myocardial infarction: investigation of 507 patients with myocardial infarction. Am Heart J 2004: 147: 897-904.
22. Pauer HU, Voigt-Tschirschwitz T, Hinney B et al. Analyzes of three common thrombophilic gene mutations in German women with recurrent abortions. Acta Obstet Gynecol Scand 2003: 82: 942-7.
23. Dierkes J, Jeckel A, Ambrosch A, Westphal S, Luley C, Boeing H. Factors explaining the difference of total homocysteine between men and women in the European Investigation Into Cancer and Nutrition Potsdam study. Metabolism 2001: 50: 640-5.
24. Rau H, Braun J, Donner H et al. The codon 17 polymorphism of the CTLA4 gene in type 2 diabetes mellitus. J Clin Endocrinol Metab 2001: 86: 653-5.
25. Wuthrich RP. Factor V Leiden mutation: potential thrombogenic role in renal vein, dialysis graft and transplant vascular thrombosis. Curr Opin Nephrol Hypertens 2001: 10: 409-14.
26. Oh J, Schaefer F, Veldmann A et al. Heterozygous prothrombin gene mutation: a new risk factor for early renal allograft thrombosis. Transplantation 1999: 68: 575-8.
27. Fischereder M, Gohring P, Schneeberger H et al. Early loss of renal transplants in patients with thrombophilia. Transplantation 1998: 65: 936-9.
28. Donner H, Braun J, Seidl C et al. Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease. J Clin Endocrinol Metab 1997: 82: 4130-2.
29. Donner H, Rau H, Walfish PG et al. CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J Clin Endocrinol Metab 1997: 82: 143-6.
30. Ligers A, Xu C, Saarinen S, Hillert J, Olerup O. The CTLA-4 gene is associated with multiple sclerosis. J Neuroimmunol 1999: 97: 182-90.
31. Seidl C, Donner H, Fischer B et al. CTLA4 codon 17 dimorphism in patients with rheumatoid arthritis. Tissue Antigens 1998: 51: 62-6.
32. Park YJ, Chung HK, Park DJ et al. Polymorphism in the promoter and exon 1 of the cytotoxic T lymphocyte antigen-4 gene associated with autoimmune thyroid disease in Koreans. Thyroid 2000: 10: 453-9.
33. De Reuver P, Pravica V, Hop W. Recipient ctla-4 +49 G/G genotype is associated with reduced incidence of acute rejection after liver transplantation. Am J Transplant 2003: 3: 1587-94.
34. Holopainen PM, Partanen JA. Linkage disequilibrium and disease-associated CTLA4 gene polymorphisms. J Immunol 2001: 167: 2457-8.